Test Code LAB90317 Drug Screen, Urine Drugs of Abuse Screen, Urine
Reporting Title
Substance Abuse Screen
Methodology
Urine drug screening results should be used for medical (eg, treatment) purposes only.
Includes amphetamines, barbiturates, benzodiazepines, cocaine, methadone, opiates, oxycodone, fentanyl, buprenorphine and tetrahydrocannabinol (THC). Confirmation of presumptive positive screening results may be requested and will be charged as separate tests.
Roche Diagnostics RMH, GMC, DMH, DH, GMH, WECC, PMC, GCMH, BH, OBH, MGH, MH, HMH, SH
Performing Laboratory
OhioHealth Laboratory Services-RMH, GMC, DH, DMH, WECC, PMH, GMH, MGH, GCMH, OBH, MH, SH, BH and HMH Core Laboratories
Specimen Requirements
Detergents and bleach interfere with this assay. A complete list of substances which do and do not interfere are available upon request.
35 mL (minimum volume: 2 mL with no possibility of confirmation) from a random urine collection in a screw-capped, plastic urine container. No preservative.
Specimen Transport Temperature
Ambient: OK
Refrigerate: OK
Frozen: OK
Reference Values
None detected
Presumptive positive cutoff concentrations
Amphetamine/methamphetamine: 1,000 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepine + metabolites: 200 ng/mL
Cocaine (benzoylecgonine): 300 ng/mL
Opiates + metabolites: 300 ng/mL
THC: 50 ng/mL
Oxycodone and oxymorphone metabolite: 100 ng/mL
Methadone: 300 ng/mL
Fentanyl: 1 ng/mL
Buprenorphine: 5 ng/mL
The following information is required for the reporting of toxicology results:
- Substances or classes of substances analyzed as part of the test
- Specimen type
- Report Status for positive results (presumptive positive, confirm if clinically indicated)
- The assay cut-off concentrations
- A statement that the results are to be used for medical purposes only
Day(s) Test Set Up
Monday through Sunday; Continuously
Test Classification and CPT Coding
80307